Deepak Bhamidipati, MD

English

Dr. Bhamidipati is a board-certified medical oncologist at SCRI Oncology Partners and the assistant director of early-phase drug development at SCRI. He has been published in several peer-reviewed journals, including JCO Precision Oncology, European Journal of Cancer, and Trends in Cancer. In 2023, he was awarded the Conquer Cancer Foundation Young Investigator Award.

Dr. Bhamidipati is committed to caring for each individual with the same care and dedication he would extend to a family member or cherished loved one. His goal is to customize his approach to address each patient’s unique circumstances and tumor characteristics, fostering an environment of open communication to collaboratively determine the best path forward. He is passionate about facilitating patient access to cutting-edge cancer therapies through participation in research studies, to ensure that patients have the best possible outcomes.